• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 21-25, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

March 21-25, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/21/11- 3/25/11N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs3/24/11Silver Spring, MDCarolyn BeckerRich Fante and Rich Buckley (AstraZeneca)Meet and Greet
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs3/21/11- 3/25/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration3/21/11- 3/25/11 N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/24/11Washington, DCN/AAmerican Lung Association National Board of Directors and Nationwide AssemblyUpdate on Tobacco Control Act Implementation
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget3/21/11- 3/25/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine3/22/11Rockville, MDSharon BenzJoel Newman (AFIA)Quarterly Meeting
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/21/11- 3/25/11 N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition3/21/11- 3/25/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs3/21/11- 3/25/11 N/AN/AN/ANo Significant Meetings
Beth Martino, Associate Commissioner for External Affairs3/24/11Silver Spring, MDMeghan ScottPatty Paul, Ned Irons (August Jackson)Communications Initiatives at FDA
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research3/21/11Bethesda, MDN/AN/APluripotent Stem Cells in Translation: Early Decisions
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health3/25/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from McKinsey GroupMedical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research3/21/11- 3/25/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/25/11Washington, DCN/ATom Stenzel (United Fresh Produce Association)Food Safety
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/25/11Silver Spring, MDBernadette Dunham, Tracey Forfa, Kevin Greenlees, Jeff Gilbert, Peter Lurie, Caitlin BoonBenjamin Cohen (Keep Antibiotics Working); Margaret Mellon, Justin Tatham (Union of Concerned Scientists); Steven Roach, Richard Wood (Food Animal Concerns Trust); Susan Vaughn Grooters (S.T.O.P. - Safe Tables Our Priority)Antimicrobial Resistance
Ralph Tyler, J.D., Chief Counsel3/21/11- 3/25/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs3/21/11- 3/25/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/21/11Bethesda, MDJudith RacoosinTom Scarnecchia, Marc Overhage (Foundation for the National Institutes of Health); Richard Hodes, Michael Lauer  (National Institutes of Health)NIH CER Coordinating Committee